Serum Gal-3 levels were significantly higher in T2D patients than those in healthy controls and showed positive correlations with glycated haemoglobin (HbA1c) and C-reactive protein, linking Gal-3 to poor glycaemic control and systemic inflammation [5]. The gene discussed is LGALS3; the disease is type 2 diabetes mellitus.